GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Kijanimicin

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act1000KijanimicinBacteroides corrodensAverage MICs (mcg/ml) (24 hours incubation)>3210.7164/antibiotics.34.1101
act1001KijanimicinBacteroides fragilisAverage MICs (mcg/ml) (24 hours incubation)>3210.7164/antibiotics.34.1101
act1002KijanimicinClostridium novyiAverage MICs (mcg/ml) (24 hours incubation)>3210.7164/antibiotics.34.1101
act1003KijanimicinClostridium septicumAverage MICs (mcg/ml) (24 hours incubation)3210.7164/antibiotics.34.1101
act1004KijanimicinBacillus subtilisAverage MICs (mcg/ml) (24 hours incubation)<0.1310.7164/antibiotics.34.1101
act1005KijanimicinStaphylococcus sp.Average MICs (mcg/ml) (24 hours incubation)6410.7164/antibiotics.34.1101
act1006KijanimicinStreptococcus sp.Average MICs (mcg/ml) (24 hours incubation)2410.7164/antibiotics.34.1101
act1007KijanimicinEscherichia coliAverage MICs (mcg/ml) (24 hours incubation)>12810.7164/antibiotics.34.1101
act1008KijanimicinKlebsiella sp.Average MICs (mcg/ml) (24 hours incubation)>12810.7164/antibiotics.34.1101
act1009KijanimicinEnterobacter sp.Average MICs (mcg/ml) (24 hours incubation)6410.7164/antibiotics.34.1101
act1010KijanimicinProteus sp.Average MICs (mcg/ml) (24 hours incubation)>12810.7164/antibiotics.34.1101
act1011KijanimicinPseudomonas aeruginosaAverage MICs (mcg/ml) (24 hours incubation)>12810.7164/antibiotics.34.1101
act1012KijanimicinSalmonella schottmuelleriAverage MICs (mcg/ml) (24 hours incubation)>12810.7164/antibiotics.34.1101
act1013KijanimicinSerratia sp.Average MICs (mcg/ml) (24 hours incubation)>12810.7164/antibiotics.34.1101
act1014KijanimicinCandida sp.Average MICs (mcg/ml) (24 hours incubation)>2510.7164/antibiotics.34.1101
act1015KijanimicinEpidermophyton floccosumAverage MICs (mcg/ml) (24 hours incubation)>2510.7164/antibiotics.34.1101
act1016KijanimicinTrichophyton sp.Average MICs (mcg/ml) (24 hours incubation)17.510.7164/antibiotics.34.1101
act1017KijanimicinMicrosporum sp.Average MICs (mcg/ml) (24 hours incubation)17.510.7164/antibiotics.34.1101
act1021KijanimicinP-388 lymphatic leukemiaTreatment schedule  Dose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5QD 1 → 9 64 150 -1.910.7164/antibiotics.34.1101
act1022KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5QD 1 → 9 32 156 -1.010.7164/antibiotics.34.1101
act1023KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5QD 1 → 9 16 139 -0.610.7164/antibiotics.34.1101
act1024KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5QD 1 → 9 8 111 -0.810.7164/antibiotics.34.1101
act1025KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5QD 1 → 9 4 111 -0.310.7164/antibiotics.34.1101
act1026KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5QD 1 → 9 2 106 -0.710.7164/antibiotics.34.1101
act1027KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1, 5&9 64 139 -1.510.7164/antibiotics.34.1101
act1028KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1, 5&9 32 117 -1.410.7164/antibiotics.34.1101
act1029KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1, 5&9 16 111 -1.010.7164/antibiotics.34.1101
act1030KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1, 5&9 8 100 -0.310.7164/antibiotics.34.1101
act1031KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1, 5&9 4 100 -1.010.7164/antibiotics.34.1101
act1032KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1, 5&9 2 100 -0.410.7164/antibiotics.34.1101
act1033KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1 128 133 -1.810.7164/antibiotics.34.1101
act1034KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1 64 111 -1.510.7164/antibiotics.34.1101
act1035KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1 32 117 -1.410.7164/antibiotics.34.1101
act1036KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1 16 111 -0.810.7164/antibiotics.34.1101
act1037KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1 8 106 -1.310.7164/antibiotics.34.1101
act1038KijanimicinP-388 lymphatic leukemiaTreatment schedule  \nDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 5Day 1 4 100 -0.810.7164/antibiotics.34.1101
act1039KijanimicinB16 melanomaDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 564 139 -1.510.7164/antibiotics.34.1101
act1040KijanimicinB16 melanomaDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 532 130 -1.210.7164/antibiotics.34.1101
act1041KijanimicinB16 melanomaDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 516 117 -0.810.7164/antibiotics.34.1101
act1042KijanimicinB16 melanomaDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 58 117 -0.810.7164/antibiotics.34.1101
act1043KijanimicinB16 melanomaDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 54 109 +0.210.7164/antibiotics.34.1101
act1044KijanimicinB16 melanomaDose, i.p. (mg/kg/inj.)\nEffect MST (% T/C)\nAverage weight change (g) Day 52 100 +0.310.7164/antibiotics.34.1101
act999KijanimicinPropionibacterium acnesAverage MICs (mcg/ml) (24 hours incubation)0.8610.7164/antibiotics.34.1101